Industry: Food & Beverages
Published Date: 2026-03-24
Pages: 191 Pages
Report ld: 6277414
Request Sample
Customized Report
Affinity Chromatography Column for Mycotoxins Market Size(US$)

CAGR 2026-2032
6.0%
Market Size,2032
USD 311
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Affinity Chromatography Column for Mycotoxins market is projected to grow from US$ 208 million in 2025 to US$ 311 million by 2032, at a CAGR of 6.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
An Affinity Chromatography Column for Mycotoxins is a specialized chromatographic column designed for the selective separation and purification of mycotoxins from complex mixtures, such as food, feed, and agricultural products. Mycotoxins are toxic compounds produced by certain molds (fungi) that can contaminate crops and pose serious health risks to humans and animals. These columns use the principles of affinity chromatography, which relies on the specific interaction between the target molecule (in this case, mycotoxins) and a ligand that is immobilized on the stationary phase of the column.
From a downstream perspective, Food accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Affinity Chromatography Column for Mycotoxins leading manufacturers (including Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM, Ring Biotechnology, R-Biopharm AG, CHROMATIFIC, Neogen, etc.), dominate supply; the top five capture approximately % of global revenue, with Gold Standard Diagnostics Horsham leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Affinity Chromatography Column for Mycotoxins market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Affinity Chromatography Column for Mycotoxins study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Affinity Chromatography Column for Mycotoxins: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Affinity Chromatography Column for Mycotoxins Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Aflatoxins
1.2.3 Ochratoxin
1.2.4 Zearalenone
1.2.5 Deoxynivalenol
1.2.6 Fumonisins
1.2.7 Others
1.3 Market Segmentation by Application
1.3.1 Global Affinity Chromatography Column for Mycotoxins Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Food
1.3.3 Feed
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Affinity Chromatography Column for Mycotoxins Revenue Estimates and Forecasts (2021-2032)
2.2 Global Affinity Chromatography Column for Mycotoxins Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Affinity Chromatography Column for Mycotoxins Sales Estimates and Forecasts (2021-2032)
2.4 Global Affinity Chromatography Column for Mycotoxins Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Affinity Chromatography Column for Mycotoxins Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Affinity Chromatography Column for Mycotoxins Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Aflatoxins: Market Share by Key Manufacturers
3.5.2 Ochratoxin: Market Share by Key Manufacturers
3.5.3 Zearalenone: Market Share by Key Manufacturers
3.5.4 Deoxynivalenol: Market Share by Key Manufacturers
3.5.5 Fumonisins: Market Share by Key Manufacturers
3.5.6 Others: Market Share by Key Manufacturers
3.6 Global Affinity Chromatography Column for Mycotoxins Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Affinity Chromatography Column for Mycotoxins Sales Performance by Type
4.1.1 Global Affinity Chromatography Column for Mycotoxins Sales Volume by Type (2021-2032)
4.1.2 Global Affinity Chromatography Column for Mycotoxins Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Affinity Chromatography Column for Mycotoxins Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Affinity Chromatography Column for Mycotoxins Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Affinity Chromatography Column for Mycotoxins Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Affinity Chromatography Column for Mycotoxins Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Affinity Chromatography Column for Mycotoxins Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Affinity Chromatography Column for Mycotoxins Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Affinity Chromatography Column for Mycotoxins Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Affinity Chromatography Column for Mycotoxins Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Affinity Chromatography Column for Mycotoxins Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Affinity Chromatography Column for Mycotoxins Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Affinity Chromatography Column for Mycotoxins Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Affinity Chromatography Column for Mycotoxins Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Gold Standard Diagnostics Horsham
11.1.1 Gold Standard Diagnostics Horsham Corporation Information
11.1.2 Gold Standard Diagnostics Horsham Business Overview
11.1.3 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.1.4 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Sales by Product in 2025
11.1.6 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Sales by Application in 2025
11.1.7 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Sales by Geographic Area in 2025
11.1.8 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins SWOT Analysis
11.1.9 Gold Standard Diagnostics Horsham Recent Developments
11.2 LCTech
11.2.1 LCTech Corporation Information
11.2.2 LCTech Business Overview
11.2.3 LCTech Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.2.4 LCTech Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 LCTech Affinity Chromatography Column for Mycotoxins Sales by Product in 2025
11.2.6 LCTech Affinity Chromatography Column for Mycotoxins Sales by Application in 2025
11.2.7 LCTech Affinity Chromatography Column for Mycotoxins Sales by Geographic Area in 2025
11.2.8 LCTech Affinity Chromatography Column for Mycotoxins SWOT Analysis
11.2.9 LCTech Recent Developments
11.3 Shimadzu
11.3.1 Shimadzu Corporation Information
11.3.2 Shimadzu Business Overview
11.3.3 Shimadzu Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.3.4 Shimadzu Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Shimadzu Affinity Chromatography Column for Mycotoxins Sales by Product in 2025
11.3.6 Shimadzu Affinity Chromatography Column for Mycotoxins Sales by Application in 2025
11.3.7 Shimadzu Affinity Chromatography Column for Mycotoxins Sales by Geographic Area in 2025
11.3.8 Shimadzu Affinity Chromatography Column for Mycotoxins SWOT Analysis
11.3.9 Shimadzu Recent Developments
11.4 Biotez Berlin
11.4.1 Biotez Berlin Corporation Information
11.4.2 Biotez Berlin Business Overview
11.4.3 Biotez Berlin Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.4.4 Biotez Berlin Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Biotez Berlin Affinity Chromatography Column for Mycotoxins Sales by Product in 2025
11.4.6 Biotez Berlin Affinity Chromatography Column for Mycotoxins Sales by Application in 2025
11.4.7 Biotez Berlin Affinity Chromatography Column for Mycotoxins Sales by Geographic Area in 2025
11.4.8 Biotez Berlin Affinity Chromatography Column for Mycotoxins SWOT Analysis
11.4.9 Biotez Berlin Recent Developments
11.5 PerkinElmer
11.5.1 PerkinElmer Corporation Information
11.5.2 PerkinElmer Business Overview
11.5.3 PerkinElmer Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.5.4 PerkinElmer Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 PerkinElmer Affinity Chromatography Column for Mycotoxins Sales by Product in 2025
11.5.6 PerkinElmer Affinity Chromatography Column for Mycotoxins Sales by Application in 2025
11.5.7 PerkinElmer Affinity Chromatography Column for Mycotoxins Sales by Geographic Area in 2025
11.5.8 PerkinElmer Affinity Chromatography Column for Mycotoxins SWOT Analysis
11.5.9 PerkinElmer Recent Developments
11.6 VICAM
11.6.1 VICAM Corporation Information
11.6.2 VICAM Business Overview
11.6.3 VICAM Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.6.4 VICAM Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 VICAM Recent Developments
11.7 Ring Biotechnology
11.7.1 Ring Biotechnology Corporation Information
11.7.2 Ring Biotechnology Business Overview
11.7.3 Ring Biotechnology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.7.4 Ring Biotechnology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Ring Biotechnology Recent Developments
11.8 R-Biopharm AG
11.8.1 R-Biopharm AG Corporation Information
11.8.2 R-Biopharm AG Business Overview
11.8.3 R-Biopharm AG Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.8.4 R-Biopharm AG Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 R-Biopharm AG Recent Developments
11.9 CHROMATIFIC
11.9.1 CHROMATIFIC Corporation Information
11.9.2 CHROMATIFIC Business Overview
11.9.3 CHROMATIFIC Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.9.4 CHROMATIFIC Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 CHROMATIFIC Recent Developments
11.10 Neogen
11.10.1 Neogen Corporation Information
11.10.2 Neogen Business Overview
11.10.3 Neogen Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.10.4 Neogen Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Neogen Recent Developments
11.11 Shenzhen Bioeasy Biotechnology
11.11.1 Shenzhen Bioeasy Biotechnology Corporation Information
11.11.2 Shenzhen Bioeasy Biotechnology Business Overview
11.11.3 Shenzhen Bioeasy Biotechnology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.11.4 Shenzhen Bioeasy Biotechnology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Shenzhen Bioeasy Biotechnology Recent Developments
11.12 Kwinbon Biotechnology
11.12.1 Kwinbon Biotechnology Corporation Information
11.12.2 Kwinbon Biotechnology Business Overview
11.12.3 Kwinbon Biotechnology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.12.4 Kwinbon Biotechnology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Kwinbon Biotechnology Recent Developments
11.13 Shandong Meizheng Bio-Tech
11.13.1 Shandong Meizheng Bio-Tech Corporation Information
11.13.2 Shandong Meizheng Bio-Tech Business Overview
11.13.3 Shandong Meizheng Bio-Tech Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.13.4 Shandong Meizheng Bio-Tech Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Shandong Meizheng Bio-Tech Recent Developments
11.14 Shandong Lvdu Bio-Sciences & Technology
11.14.1 Shandong Lvdu Bio-Sciences & Technology Corporation Information
11.14.2 Shandong Lvdu Bio-Sciences & Technology Business Overview
11.14.3 Shandong Lvdu Bio-Sciences & Technology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.14.4 Shandong Lvdu Bio-Sciences & Technology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Shandong Lvdu Bio-Sciences & Technology Recent Developments
11.15 Beijing Nano-Ace Technology
11.15.1 Beijing Nano-Ace Technology Corporation Information
11.15.2 Beijing Nano-Ace Technology Business Overview
11.15.3 Beijing Nano-Ace Technology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.15.4 Beijing Nano-Ace Technology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Beijing Nano-Ace Technology Recent Developments
11.16 Pribolab
11.16.1 Pribolab Corporation Information
11.16.2 Pribolab Business Overview
11.16.3 Pribolab Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.16.4 Pribolab Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Pribolab Recent Developments
11.17 Jiangsu Suwei Micro-Biology Research
11.17.1 Jiangsu Suwei Micro-Biology Research Corporation Information
11.17.2 Jiangsu Suwei Micro-Biology Research Business Overview
11.17.3 Jiangsu Suwei Micro-Biology Research Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.17.4 Jiangsu Suwei Micro-Biology Research Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Jiangsu Suwei Micro-Biology Research Recent Developments
11.18 BIOCOMMA
11.18.1 BIOCOMMA Corporation Information
11.18.2 BIOCOMMA Business Overview
11.18.3 BIOCOMMA Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.18.4 BIOCOMMA Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 BIOCOMMA Recent Developments
11.19 Jiangsu Wisdom Engineering & Technology
11.19.1 Jiangsu Wisdom Engineering & Technology Corporation Information
11.19.2 Jiangsu Wisdom Engineering & Technology Business Overview
11.19.3 Jiangsu Wisdom Engineering & Technology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.19.4 Jiangsu Wisdom Engineering & Technology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Jiangsu Wisdom Engineering & Technology Recent Developments
11.20 Anavo
11.20.1 Anavo Corporation Information
11.20.2 Anavo Business Overview
11.20.3 Anavo Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.20.4 Anavo Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Anavo Recent Developments
11.21 Prufunglab
11.21.1 Prufunglab Corporation Information
11.21.2 Prufunglab Business Overview
11.21.3 Prufunglab Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.21.4 Prufunglab Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Prufunglab Recent Developments
11.22 Femdetection
11.22.1 Femdetection Corporation Information
11.22.2 Femdetection Business Overview
11.22.3 Femdetection Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.22.4 Femdetection Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Femdetection Recent Developments
11.23 Welch Materials
11.23.1 Welch Materials Corporation Information
11.23.2 Welch Materials Business Overview
11.23.3 Welch Materials Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.23.4 Welch Materials Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Welch Materials Recent Developments
11.24 Wuhan Huamei Wisherkon Biotech
11.24.1 Wuhan Huamei Wisherkon Biotech Corporation Information
11.24.2 Wuhan Huamei Wisherkon Biotech Business Overview
11.24.3 Wuhan Huamei Wisherkon Biotech Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.24.4 Wuhan Huamei Wisherkon Biotech Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 Wuhan Huamei Wisherkon Biotech Recent Developments
11.25 Shandong Vnya Bio-technology
11.25.1 Shandong Vnya Bio-technology Corporation Information
11.25.2 Shandong Vnya Bio-technology Business Overview
11.25.3 Shandong Vnya Bio-technology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications
11.25.4 Shandong Vnya Bio-technology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 Shandong Vnya Bio-technology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Affinity Chromatography Column for Mycotoxins Industry Chain
12.2 Affinity Chromatography Column for Mycotoxins Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Affinity Chromatography Column for Mycotoxins Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Affinity Chromatography Column for Mycotoxins Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Affinity Chromatography Column for Mycotoxins Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Affinity Chromatography Column for Mycotoxins Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Affinity Chromatography Column for Mycotoxins market size was US$ 208 million in 2025 and is forecast to reach a readjusted size of US$ 311 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 116
USD 4250.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 208 million in 2025 and is projected to reach US$ 311 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 164
USD 3950.00
(Single User License)
The global Affinity Chromatography Column for Mycotoxins market was valued at US$ 208 million in 2025 and is anticipated to reach US$ 311 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 144
USD 2900.00
(Single User License)
The global Affinity Chromatography Column for Mycotoxins market is projected to grow from US$ 187 million in 2024 to US$ 280 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 197
USD 4900.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 151
USD 3950.00
(Single User License)
The global Affinity Chromatography Column for Mycotoxins market size was US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 116
USD 4250.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was valued at US$ 187 million in the year 2024 and is projected to reach a revised size of US$ 280 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published Date: 2025-03-13
Pages: 113
USD 2900.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 168
USD 3950.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2023 and is forecast to a readjusted size of US$ 280 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030.
Published Date: 2025-01-04
Pages: 168
USD 3950.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was valued at US$ 187 million in the year 2023 and is projected to reach a revised size of US$ 280 million by 2030, growing at a CAGR of 6.0% during the forecast period.
Published Date: 2025-01-04
Pages: 108
USD 2900.00
(Single User License)
The global Affinity Chromatography Column for Mycotoxins market size was US$ 208 million in 2025 and is forecast to reach a readjusted size of US$ 311 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 116
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 208 million in 2025 and is projected to reach US$ 311 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 164
The global Affinity Chromatography Column for Mycotoxins market was valued at US$ 208 million in 2025 and is anticipated to reach US$ 311 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 144
The global Affinity Chromatography Column for Mycotoxins market is projected to grow from US$ 187 million in 2024 to US$ 280 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 197
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 151
The global Affinity Chromatography Column for Mycotoxins market size was US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 116
The global market for Affinity Chromatography Column for Mycotoxins was valued at US$ 187 million in the year 2024 and is projected to reach a revised size of US$ 280 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-03-13
Pages: 113
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 168
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2023 and is forecast to a readjusted size of US$ 280 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030.
Published: 2025-01-04
Pages: 168
The global market for Affinity Chromatography Column for Mycotoxins was valued at US$ 187 million in the year 2023 and is projected to reach a revised size of US$ 280 million by 2030, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-01-04
Pages: 108
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now